Bon TEV
Di bawah adalah senarai bon-bon korporat TEVA PHARMACEUT. SP.ADR. Pelabur selalunya memilih bon syarikat kerana kestabilan meningkat mereka semasa ketidakstabilan pasaran. Kaji harga, hasil dan statistik lain dan cari pelaburan yang boleh dipercayai.
Simbol | YTM % | Volum | Harga % | Kupon % | Tarikh Matang | Jumlah tertunggak | Nilai muka | Jumlah denominasi min | Pengeluar |
---|---|---|---|---|---|---|---|---|---|
TTEVA.GJTeva Pharmaceutical Finance Co. LLC 0.25% 01-FEB-2026 | 26.91% | 2 K | 85.00% | 0.25% | 2026-02-01 | 22.88 M USD | 1,000.00 USD | 1,000.00 USD | Teva Pharmaceutical Finance Co. LLC |
TTFACTEVA P.FI.NL III 16/46 | 7.88% | 0 | 69.94% | 4.10% | 2046-10-01 | 2 B USD | 1,000.00 USD | 2,000.00 USD | Teva Pharmaceutical Finance Netherlands III BV |
TTEVA4608603Teva Pharmaceutical Finance Netherlands III BV 6.75% 01-MAR-2028 | 6.96% | 1 M | 99.25% | 6.75% | 2028-03-01 | 255 K USD | 1,000.00 USD | 200,000.00 USD | Teva Pharmaceutical Finance Netherlands III BV |
UUS88163VAD1TEVA PHARM.FIN. 2036 | 6.09% | 0 | 100.40% | 6.15% | 2036-02-01 | 789.43 M USD | 1,000.00 USD | 2,000.00 USD | Teva Pharmaceutical Finance Co. LLC |
TTEVA4608604Teva Pharmaceutical Finance Netherlands III BV 6.75% 01-MAR-2028 | 5.93% | 80 K | 101.93% | 6.75% | 2028-03-01 | 1.25 B USD | 1,000.00 USD | 200,000.00 USD | Teva Pharmaceutical Finance Netherlands III BV |
TTEVA6082388Teva Pharmaceutical Finance Netherlands III BV 6.0% 01-DEC-2032 | 5.69% | 355 K | 101.65% | 6.00% | 2032-12-01 | 500 M USD | 1,000.00 USD | 200,000.00 USD | Teva Pharmaceutical Finance Netherlands III BV |
TTEVA5549924Teva Pharmaceutical Finance Netherlands III BV 8.125% 15-SEP-2031 | 5.59% | 1.9 M | 111.77% | 8.13% | 2031-09-15 | 500 M USD | 1,000.00 USD | 200,000.00 USD | Teva Pharmaceutical Finance Netherlands III BV |
TTFABTEVA P.FI.NL III 16/26 | 5.57% | 0 | 97.05% | 3.15% | 2026-10-01 | 1.8 B USD | 1,000.00 USD | 2,000.00 USD | Teva Pharmaceutical Finance Netherlands III BV |
TTEVA5549923Teva Pharmaceutical Finance Netherlands III BV 7.875% 15-SEP-2029 | 5.53% | 400 K | 108.12% | 7.88% | 2029-09-15 | 397.68 M USD | 1,000.00 USD | 200,000.00 USD | Teva Pharmaceutical Finance Netherlands III BV |
TTEVA6082389Teva Pharmaceutical Finance Netherlands IV BV 5.75% 01-DEC-2030 | 5.51% | 4 M | 101.00% | 5.75% | 2030-12-01 | 700 M USD | 1,000.00 USD | 200,000.00 USD | Teva Pharmaceutical Finance Netherlands IV BV |
TTEVA5295244Teva Pharmaceutical Finance Netherlands III BV 4.75% 09-MAY-2027 | 5.43% | 150 K | 98.82% | 4.75% | 2027-05-09 | 649.12 M USD | 1,000.00 USD | 200,000.00 USD | Teva Pharmaceutical Finance Netherlands III BV |
TTEVA5295245Teva Pharmaceutical Finance Netherlands III BV 5.125% 09-MAY-2029 | 5.39% | 1.62 M | 99.13% | 5.13% | 2029-05-09 | 1 B USD | 1,000.00 USD | 200,000.00 USD | Teva Pharmaceutical Finance Netherlands III BV |
XXS308179796TEV.P.F.N.II 25/31 | 4.00% | 0 | 100.60% | 4.13% | 2031-06-01 | 1 B EUR | 1,000.00 EUR | 100,000.00 EUR | Teva Pharmaceutical Finance Netherlands II BV |
XXS259280419TEV.P.F.N.II 23/31 | 3.89% | 0 | 120.09% | 7.88% | 2031-09-15 | 500 M EUR | 1,000.00 EUR | 100,000.00 EUR | Teva Pharmaceutical Finance Netherlands II BV |
CCH33382750TEVA PH.FI.NL IV 16-25 | 3.85% | 0 | 99.63% | 1.00% | 2025-07-28 | 350 M CHF | 5,000.00 CHF | 5,000.00 CHF | Teva Pharmaceutical Finance Netherlands IV BV |
XXS240660717TEV.P.F.N.II 21/30 | 3.80% | 0 | 102.39% | 4.38% | 2030-05-09 | 1.5 B EUR | 1,000.00 EUR | 100,000.00 EUR | Teva Pharmaceutical Finance Netherlands II BV |
XXS259280443TEV.P.F.N.II 23/29 | 3.64% | 0 | 113.78% | 7.38% | 2029-09-15 | 662.58 M EUR | 1,000.00 EUR | 100,000.00 EUR | Teva Pharmaceutical Finance Netherlands II BV |
XXS240660709TEV.P.F.N.II 21/27 | 3.37% | 0 | 100.68% | 3.75% | 2027-05-09 | 1.1 B EUR | 1,000.00 EUR | 100,000.00 EUR | Teva Pharmaceutical Finance Netherlands II BV |
XXS121104407TEVA PH.F.NL.II 15/27 | 3.31% | 0 | 97.55% | 1.88% | 2027-03-31 | 700 M EUR | 1,000.00 EUR | 100,000.00 EUR | Teva Pharmaceutical Finance Netherlands II BV |
XXS143974936TEVA PH.F.NL.II 16/28 | 3.24% | 0 | 95.11% | 1.63% | 2028-10-15 | 750 M EUR | 1,000.00 EUR | 100,000.00 EUR | Teva Pharmaceutical Finance Netherlands II BV |